IP Verse

Pharmaceutical Anti-Tnf-Alpha Antibody Formulation

EP3212667

RICHTER GEDEON NYRT.
Application Number
EP15808356A
Filing Date
Oct 28, 2015
Status
Granted And Under Opposition
Aug 17, 2018
Grant Date
Sep 19, 2018
External Links
Slate, Register

Biblio Summary

The patent EP3212667B1 was granted on Sep 19, 2018 by Richter Gedeon Nyrt. The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 3 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SAMSUNG BIOEPIS NL B.V.Dec 12, 2019INTERVENTION WITHDRAWN
BIOGEN INC.Jun 19, 2019WITHDRAWN
SAMSUNG BIOEPIS UK LIMITEDJun 19, 2019WITHDRAWN

More Opposed Patents of Richter Gedeon Nyrt.

The table below shows the patents of Richter Gedeon Nyrt. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3877395Industrial Process For The Preparation Of High Purity EstetrolDec 7, 20221
EP2925324Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of SchizophreniaDec 30, 20202
EP2828396Method For The Production Of PolypeptidesApr 24, 20191

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents